- Home
- BCE vs TEVA Comparison
BCE vs TEVA Comparison
Compare BCE & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCE
- TEVA
- Stock Information
- Founded
- BCE 1880
- TEVA 1901
- Country
- BCE Canada
- TEVA Israel
- Employees
- BCE N/A
- TEVA N/A
- Industry
- BCE
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- BCE
- TEVA Health Care
- Exchange
- BCE Nasdaq
- TEVA Nasdaq
- Market Cap
- BCE 20.2B
- TEVA 21.2B
- IPO Year
- BCE N/A
- TEVA N/A
- Fundamental
- Price
- BCE $23.11
- TEVA $20.03
- Analyst Decision
- BCE Hold
- TEVA Strong Buy
- Analyst Count
- BCE 4
- TEVA 7
- Target Price
- BCE $33.50
- TEVA $25.57
- AVG Volume (30 Days)
- BCE 3.4M
- TEVA 8.7M
- Earning Date
- BCE 11-06-2025
- TEVA 11-05-2025
- Dividend Yield
- BCE 5.46%
- TEVA N/A
- EPS Growth
- BCE N/A
- TEVA N/A
- EPS
- BCE 0.35
- TEVA N/A
- Revenue
- BCE $17,896,265,003.00
- TEVA $16,628,000,000.00
- Revenue This Year
- BCE $2.03
- TEVA $4.37
- Revenue Next Year
- BCE $2.87
- TEVA $0.67
- P/E Ratio
- BCE $66.89
- TEVA N/A
- Revenue Growth
- BCE N/A
- TEVA 2.08
- 52 Week Low
- BCE $20.28
- TEVA $12.47
- 52 Week High
- BCE $32.48
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- BCE 41.07
- TEVA 58.64
- Support Level
- BCE $23.24
- TEVA $18.83
- Resistance Level
- BCE $23.77
- TEVA $20.62
- Average True Range (ATR)
- BCE 0.60
- TEVA 0.48
- MACD
- BCE -0.04
- TEVA 0.01
- Stochastic Oscillator
- BCE 29.93
- TEVA 67.13
About BCE BCE Inc.
BCE provides wireless, broadband, television, and landline phone services in Canada. It is one of the Big Three national wireless carriers, with over 10 million customers constituting about 30% of the market. It is also the incumbent local exchange carrier—the legacy telephone provider—throughout much of the eastern half of Canada, including in the most populous Canadian provinces: Ontario and Quebec. BCE has a media segment that holds television, radio, and digital media assets. BCE licenses the Canadian rights to movie channels including HBO, Showtime, and Starz.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.